Mosa Meat, a Maastricht, Netherlands-based food technology company, held first closing of $55M as part of a larger Series B funding round.
Lava Therapeutics, an Utrecht, The Netherlands- and Philadelphia, PA-based biotech company pioneering the development of bispecific antibodies to engage gamma-delta T cells for cancer therapies, closed an $83m (€71m) Series C financing.
Factris, an Amsterdam, The Netherlands-based fintech company that buys unpaid invoices from businesses, providing instant capital, closed a €5M Series A equity funding.
Mollie, an Amsterdam, The Netherlands-based payment service provider, closed a 90m Euro (US$100m) Series B funding round.
IME Medical Electrospinning, a Waalre, The Netherlands-based global leader in electrospun medical devices and regenerative medicine, raised €3m in equity and debt financing.
Capsa Healthcare, a Portland, Oregon-based provider of healthcare delivery solutions for hospital, senior care and pharmacy settings, acquired RoboPharma, a pharmacy automation leader based in Waalwijk, The Netherlands.
Castor, a Hoboken, N.J.- and Amsterdam, The Netherlands-based provider of clinical trial technology that automates the research process, raised $12m in funding.
Rabo Frontier Ventures has entered into a partnership with London, UK-based Greyhound Capital through a commitment to their second fund, Greyhound Capital Partners II, L.P.
Siilo, an Amsterdam, The Netherlands – based secure collaboration app for healthcare professionals, raised an £8.6m (€9.5m) in Series A funding.
Vico Therapeutics, a Leiden, Netherlands-based biotech company focusing on the development of RNA modulating therapies for rare neurological disorders, raised $31m (€27m) in Series A financing round.
Enzyre, a Nijmegen, The Netherlands-based developer of diagnostic technology, received a €1.4m Corona Bridge Loan.
Energyworx, a Houston, Texas, USA- and Houten, The Netherlands-based provider of cloud Energy Data Management solutions, received a strategic investment from ENGIE, through its venture capital arm ENGIE New Ventures.
Connecterra, an Amsterdam, Netherlands-based predictive analytics and livestock monitoring software company, raised USD 7.8m in Series B funding.
Harbour BioMed, a Cambridge, MA, Rotterdam, NL, and Suzhou CN-based global, clinical stage biopharmaceutical company, completd its Series C financing of $102.8M.
Ace & Tate, an Amsterdam, The Netherlands-based eyewear brand, raised €14.25m in funding.